Liu CH, Yang ST, Chao WT, Lin CH, et al. Targeting the ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) as a potential therapeutic strategy to overcome anti-VEGF resistance in endometrial cancer. Int J Gynaecol Obstet 2025 Jun 11. doi: 10.1002/ijgo.70292.
PMID: 40497576